Kav et al. (2017) [15] showed that tissue levels of IL-6 and TNF-α were greatly decreased in the Azelnidipine-treated group of mice with dextran sulphate sodium (DSS)-induced colitis, suggesting Azelnidipine anti-inflammatory effect. This evidence concerns the gene IL6 and colitis.